Aviva Goel Beckmann

Aviva Goel Beckmann, PhD, currently serves as Vice President of Precision Medicine at Pathos, a position held since August 2023. Previously, Aviva was Principal Scientist and Emerging Research Lead at GeneDx, where leadership was provided to a cross-functional team for real-world evidence research in immune and inflammatory diseases, including a notable collaboration with Sanofi. Aviva also held a similar role at Sema4, focusing on I&I diseases and database curation. Academic training includes a PhD in Developmental and Stem Cell Biology from the Icahn School of Medicine at Mount Sinai, complemented by early research experience at Memorial Sloan-Kettering Cancer Center and a graduate education underpinned by foundational studies at Lafayette College and Kodaikanal International School.